@neuralstemcells.bsky.social
Neural Stem Cell Institute (NSCI), the research arm of the Regenerative Research Foundation. 501(c)3 non-profit stem cell research organization. Developing regenerative therapies for the nervous system.
Pinned
Early results from our Luxa Biotech-sponsored and #NEIfunded #ClinicalTrial are out in #CellStemCell. The trial uses an adult RPE stem cell therapy for dry age-related #MacularDegeneration.
Beautiful cover art by Dr. Yangzi Isabel Tian.
Full Text | zurl.co/gQ2bq
@cellpress.bsky.social
#NIHfunded
Beautiful cover art by Dr. Yangzi Isabel Tian.
Full Text | zurl.co/gQ2bq
@cellpress.bsky.social
#NIHfunded
Early results from our Luxa Biotech-sponsored and #NEIfunded #ClinicalTrial are out in #CellStemCell. The trial uses an adult RPE stem cell therapy for dry age-related #MacularDegeneration.
Beautiful cover art by Dr. Yangzi Isabel Tian.
Full Text | zurl.co/gQ2bq
@cellpress.bsky.social
#NIHfunded
Beautiful cover art by Dr. Yangzi Isabel Tian.
Full Text | zurl.co/gQ2bq
@cellpress.bsky.social
#NIHfunded
November 7, 2025 at 3:53 AM
Early results from our Luxa Biotech-sponsored and #NEIfunded #ClinicalTrial are out in #CellStemCell. The trial uses an adult RPE stem cell therapy for dry age-related #MacularDegeneration.
Beautiful cover art by Dr. Yangzi Isabel Tian.
Full Text | zurl.co/gQ2bq
@cellpress.bsky.social
#NIHfunded
Beautiful cover art by Dr. Yangzi Isabel Tian.
Full Text | zurl.co/gQ2bq
@cellpress.bsky.social
#NIHfunded
Have a safe and happy Halloween!
October 31, 2025 at 6:45 PM
Have a safe and happy Halloween!
Stem cell research is opening new doors for treating age-related #MacularDegeneration (AMD), a leading cause of vision loss.
Join our co-founders, Drs. Jeffrey Stern and Sally Temple on @BrightFocus Foundation's Macular Chat on Wed, Oct 29.
Join our co-founders, Drs. Jeffrey Stern and Sally Temple on @BrightFocus Foundation's Macular Chat on Wed, Oct 29.
October 24, 2025 at 1:40 PM
Stem cell research is opening new doors for treating age-related #MacularDegeneration (AMD), a leading cause of vision loss.
Join our co-founders, Drs. Jeffrey Stern and Sally Temple on @BrightFocus Foundation's Macular Chat on Wed, Oct 29.
Join our co-founders, Drs. Jeffrey Stern and Sally Temple on @BrightFocus Foundation's Macular Chat on Wed, Oct 29.
Reposted
Less than two weeks left to register for the inaugural conference on Assembloids & Complex Cell-Cell Interactions at @cshlnews.bsky.social
Check out the topics and amazing lineup of speakers!
Check out the topics and amazing lineup of speakers!
October 3, 2025 at 8:04 AM
Less than two weeks left to register for the inaugural conference on Assembloids & Complex Cell-Cell Interactions at @cshlnews.bsky.social
Check out the topics and amazing lineup of speakers!
Check out the topics and amazing lineup of speakers!
A great piece by our friends at Michigan Medicine! We are grateful to have our first clinical trial in the skilled hands of Drs. Rajesh Rao of Kellogg Eye Center, David Liao of LA Retina and Theodore Leng of Stanford Medicine.
Article | zurl.co/0eUMo
Article | zurl.co/0eUMo
Adult stem cells show therapeutic promise in treating vision loss from macular degeneration
Researchers used retinal pigment epithelial stem cells derived from adult postmortem eye tissue in a phase 1/2a clinical trial. This is the first treatment to show promise for age-related macular degeneration or AMD.
zurl.co
September 26, 2025 at 11:38 AM
A great piece by our friends at Michigan Medicine! We are grateful to have our first clinical trial in the skilled hands of Drs. Rajesh Rao of Kellogg Eye Center, David Liao of LA Retina and Theodore Leng of Stanford Medicine.
Article | zurl.co/0eUMo
Article | zurl.co/0eUMo
Science fun on this beautiful Friday in Albany! The Capital District Postdoc Association held their annual symposium at the University at Albany. NSCI was well represented by CDPA president Sol Toruella, presenters Runia Roy & Catherine Hamann, and new postdocs Jenica Acheta & Alexis Guevara!
September 19, 2025 at 9:00 PM
Science fun on this beautiful Friday in Albany! The Capital District Postdoc Association held their annual symposium at the University at Albany. NSCI was well represented by CDPA president Sol Toruella, presenters Runia Roy & Catherine Hamann, and new postdocs Jenica Acheta & Alexis Guevara!
Big news! Early results from Cohort 1 of our Luxa Biotechnology-sponsored and #NEIfunded clinical trial are now available online at Cell Stem Cell!
Open Access Full Text | zurl.co/piAT4
#NIHfunded #MacularDegeneration #ClinicalTrials
Open Access Full Text | zurl.co/piAT4
#NIHfunded #MacularDegeneration #ClinicalTrials
Safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration: Low-dose clinical outcomes
Retinal pigment epithelium (RPE) cell loss in dry age-related macular degeneration
leads to progressive vision decline. Stern and others implanted adult RPE stem cell-derived
RPE progeny at a 4-week p...
zurl.co
September 18, 2025 at 5:05 AM
Big news! Early results from Cohort 1 of our Luxa Biotechnology-sponsored and #NEIfunded clinical trial are now available online at Cell Stem Cell!
Open Access Full Text | zurl.co/piAT4
#NIHfunded #MacularDegeneration #ClinicalTrials
Open Access Full Text | zurl.co/piAT4
#NIHfunded #MacularDegeneration #ClinicalTrials
Available now at @stemcellreports.bsky.social: Our #NEIfunded study led by Farhad Farjood, Nathan Boles and Jeffrey Stern reveals the surprising heterogeneity of retinal pigment epithelium cells in the human eye using single cell transcriptomics and proteomics.
Single-cell transcriptome and surfaceome profiling of the adult human retinal pigment epithelium
Farjood et al. has set the stage for characterizing RPE heterogeneity by using single-cell
sequencing technology to identify cell surface markers compatible with isolating each
subpopulation for furth...
zurl.co
September 4, 2025 at 5:44 AM
Available now at @stemcellreports.bsky.social: Our #NEIfunded study led by Farhad Farjood, Nathan Boles and Jeffrey Stern reveals the surprising heterogeneity of retinal pigment epithelium cells in the human eye using single cell transcriptomics and proteomics.
🔊 Are you a detail-oriented PhD scientist with cell biology or #biomanufacturing experience? Interested in development of a novel clinical stage cell replacement therapy for dry age-related #MacularDegeneration (AMD)? We are #hiring!
Learn more: zurl.co/uwrDd
Learn more: zurl.co/uwrDd
August 11, 2025 at 11:55 AM
🔊 Are you a detail-oriented PhD scientist with cell biology or #biomanufacturing experience? Interested in development of a novel clinical stage cell replacement therapy for dry age-related #MacularDegeneration (AMD)? We are #hiring!
Learn more: zurl.co/uwrDd
Learn more: zurl.co/uwrDd
Today, Liz Fisher presents "PLD3 contributions to vascular dysfunction in the context of AD" during the poster session at #AAIC2025!
Poster | #107171
Time | 7:30AM – 4:15PM
Where | Exhibit Hall
Poster | #107171
Time | 7:30AM – 4:15PM
Where | Exhibit Hall
July 29, 2025 at 1:40 AM
Today, Liz Fisher presents "PLD3 contributions to vascular dysfunction in the context of AD" during the poster session at #AAIC2025!
Poster | #107171
Time | 7:30AM – 4:15PM
Where | Exhibit Hall
Poster | #107171
Time | 7:30AM – 4:15PM
Where | Exhibit Hall
Today at #AAIC2025: Taylor Bertucci presents "APOE4 alters vascular cells in cognitively normal brains and in vitro models revealing early pathogenic AD contributions of endothelial cells."
Session | Dissecting molecular disease mechanisms
Time | 2:00 – 3:30PM
Location | Hall G
Session | Dissecting molecular disease mechanisms
Time | 2:00 – 3:30PM
Location | Hall G
July 27, 2025 at 11:36 AM
Today at #AAIC2025: Taylor Bertucci presents "APOE4 alters vascular cells in cognitively normal brains and in vitro models revealing early pathogenic AD contributions of endothelial cells."
Session | Dissecting molecular disease mechanisms
Time | 2:00 – 3:30PM
Location | Hall G
Session | Dissecting molecular disease mechanisms
Time | 2:00 – 3:30PM
Location | Hall G
Coming up at #AAIC2025, Taylor Bertucci and Liz Fisher will present data related to APOE and PLD3 contributions to vascular dysfunction in #Alzheimers Disease. Check it out!
Alzheimer's Association | zurl.co/jgQ7m
Alzheimer's Association | zurl.co/jgQ7m
AAIC | July 27-31, 2025 | Alzheimer's Association
The Alzheimer's Association International Conference is the world's largest forum for the dementia research community. Toronto, Canada, and online.
zurl.co
July 21, 2025 at 12:24 PM
Coming up at #AAIC2025, Taylor Bertucci and Liz Fisher will present data related to APOE and PLD3 contributions to vascular dysfunction in #Alzheimers Disease. Check it out!
Alzheimer's Association | zurl.co/jgQ7m
Alzheimer's Association | zurl.co/jgQ7m
📣 Just announced! Susan Sharfstein of @sunypolytechnic.bsky.social led a successful #FutureManufacturing grant application to develop next generation devices enabling advanced real-time measurement and manipulation in cellular systems.
#NSFfunded
#NSFfunded
June 13, 2025 at 7:16 PM
📣 Just announced! Susan Sharfstein of @sunypolytechnic.bsky.social led a successful #FutureManufacturing grant application to develop next generation devices enabling advanced real-time measurement and manipulation in cellular systems.
#NSFfunded
#NSFfunded
We had a terrific time with the #NIIMBLeXperience students hosted by ACPHS and the Stack Family Center for Biopharmaceutical Education and Training (CBET) program! These students are the future of pharmacy, biomanufacturing, bioengineering, and cell science. We love to see it!
June 3, 2025 at 10:00 PM
We had a terrific time with the #NIIMBLeXperience students hosted by ACPHS and the Stack Family Center for Biopharmaceutical Education and Training (CBET) program! These students are the future of pharmacy, biomanufacturing, bioengineering, and cell science. We love to see it!
Proceedings from the 2024 Global Tau Conference are available through the @alzassociation.bsky.social in collaboration with @CurePSP and the #RainwaterCharitableTrust.
Full text | zurl.co/0AnwI
Full text | zurl.co/0AnwI
Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference
Abstract Recent years have seen major advances in tau-associated brain disorders through interdisciplinary research spanning molecular biology, neuroimaging, clinical trials, and therapeutic develo...
zurl.co
June 2, 2025 at 12:16 PM
Proceedings from the 2024 Global Tau Conference are available through the @alzassociation.bsky.social in collaboration with @CurePSP and the #RainwaterCharitableTrust.
Full text | zurl.co/0AnwI
Full text | zurl.co/0AnwI
@reppaultonko.bsky.social, we were delighted to discuss our work with you today! We deeply appreciate your advocacy in support of our shared goal - to improve healthcare for patients and ultimately develop cures for Alzheimer's Disease, Macular Degeneration and other neurodegenerative conditions.
Today, I stopped by @neuralstemcells.bsky.social new facility in Albany to learn more about how NIH grants are helping this small, nonprofit institution perform groundbreaking research and develop new therapies for neurodegenerative conditions like Alzheimer’s disease.
May 29, 2025 at 7:41 PM
@reppaultonko.bsky.social, we were delighted to discuss our work with you today! We deeply appreciate your advocacy in support of our shared goal - to improve healthcare for patients and ultimately develop cures for Alzheimer's Disease, Macular Degeneration and other neurodegenerative conditions.
We were thrilled to host Dr. Kristen Brennand of @Yale University this week! She gave a terrific talk on "Using Stem Cells to Explore the Genetics Underlying Brain Disease."
#Schizophrenia
#StemCell
@kristenbrennand.bsky.social
#Schizophrenia
#StemCell
@kristenbrennand.bsky.social
May 22, 2025 at 8:58 PM
We were thrilled to host Dr. Kristen Brennand of @Yale University this week! She gave a terrific talk on "Using Stem Cells to Explore the Genetics Underlying Brain Disease."
#Schizophrenia
#StemCell
@kristenbrennand.bsky.social
#Schizophrenia
#StemCell
@kristenbrennand.bsky.social
Congrats to the winners and to everyone who completed the @CDPHP #WorkforceTeamChallenge!
@timesunion.com coverage | zurl.co/DDAjZ
@timesunion.com coverage | zurl.co/DDAjZ
Jared Lamson, Karen Bertasso-Hughes win 2025 CDPHP Workforce Challenge in Albany
Jared Lamson and Karen Bertasso-Hughes claimed top honors at the 2025 CDPHP Workforce Team Challenge in Albany, finishing first in the 3.5-mile race.
zurl.co
May 17, 2025 at 12:13 AM
Congrats to the winners and to everyone who completed the @CDPHP #WorkforceTeamChallenge!
@timesunion.com coverage | zurl.co/DDAjZ
@timesunion.com coverage | zurl.co/DDAjZ
Reposted
Lamson broke away from runner-up Jack Huber of Delmar around the two-mile mark and never looked back in finishing in 17:06. On the women’s side, Karen Bertasso-Hughes of Selkirk added to her storied resume, claiming her sixth career Workforce Challenge title with a time of 20:05.
Jared Lamson, Karen Bertasso-Hughes win 2025 CDPHP Workforce Challenge in Albany
Jared Lamson and Karen Bertasso-Hughes claimed top honors at the 2025 CDPHP Workforce Team Challenge in Albany, finishing first in the 3.5-mile race.
www.timesunion.com
May 16, 2025 at 10:18 PM
Lamson broke away from runner-up Jack Huber of Delmar around the two-mile mark and never looked back in finishing in 17:06. On the women’s side, Karen Bertasso-Hughes of Selkirk added to her storied resume, claiming her sixth career Workforce Challenge title with a time of 20:05.
We had a blast at the CDPHP #WorkForceChallenge! Jack Huber took 2nd place overall for the 2nd year in a row and the whole team enjoyed the event.
@drkiehl.bsky.social
@gliaandcake.bsky.social
@drkiehl.bsky.social
@gliaandcake.bsky.social
May 16, 2025 at 4:41 PM
We had a blast at the CDPHP #WorkForceChallenge! Jack Huber took 2nd place overall for the 2nd year in a row and the whole team enjoyed the event.
@drkiehl.bsky.social
@gliaandcake.bsky.social
@drkiehl.bsky.social
@gliaandcake.bsky.social
What a week! Many thanks to the #ARVO2025 organizers for a terrific meeting! We loved spending time with great colleagues, catching up with old friends and hearing about so much inspiring #VisionResearch 👀 in beautiful #SaltLakeCity.
@arvoinfo.bsky.social
@arvoinfo.bsky.social
May 9, 2025 at 12:01 AM
What a week! Many thanks to the #ARVO2025 organizers for a terrific meeting! We loved spending time with great colleagues, catching up with old friends and hearing about so much inspiring #VisionResearch 👀 in beautiful #SaltLakeCity.
@arvoinfo.bsky.social
@arvoinfo.bsky.social
That's a wrap! Sally Temple, Taylor Bertucci and Kate Tubbesing all spoke at the annual #NIHfunded Alzheimer's Disease Sequencing Project #FunctionalGenomics meeting at the @gladstoneinst.bsky.social.
#ADSP #FunGen #Alzheimers
#ADSP #FunGen #Alzheimers
May 8, 2025 at 1:55 AM
That's a wrap! Sally Temple, Taylor Bertucci and Kate Tubbesing all spoke at the annual #NIHfunded Alzheimer's Disease Sequencing Project #FunctionalGenomics meeting at the @gladstoneinst.bsky.social.
#ADSP #FunGen #Alzheimers
#ADSP #FunGen #Alzheimers
Today! Jeff Stern presents "Safety & Tolerability of RPE Stem Cell-derived RPE Implantation in Patients with Dry Age-related #MacularDegeneration: Early Low Dose Clinical Outcomes"
Session Title | Clinical advances in cell & gene therapy
Time | 8:30 - 10:15AM
Room | Ballroom B
#ARVO2025
Session Title | Clinical advances in cell & gene therapy
Time | 8:30 - 10:15AM
Room | Ballroom B
#ARVO2025
May 6, 2025 at 12:01 PM
Today! Jeff Stern presents "Safety & Tolerability of RPE Stem Cell-derived RPE Implantation in Patients with Dry Age-related #MacularDegeneration: Early Low Dose Clinical Outcomes"
Session Title | Clinical advances in cell & gene therapy
Time | 8:30 - 10:15AM
Room | Ballroom B
#ARVO2025
Session Title | Clinical advances in cell & gene therapy
Time | 8:30 - 10:15AM
Room | Ballroom B
#ARVO2025
Today @ #ARVO2025: Brigitte Arduini will present "Preclinical safety and efficacy of an adult progenitor cell product, RPESC-RPE-4W, as therapy for dry Age-Related #MacularDegeneration"
Session Info
Title | Stem cell and gene therapy
Time | 3:15 - 5pm (talk @ 3:15pm)
Room | 255E
Session Info
Title | Stem cell and gene therapy
Time | 3:15 - 5pm (talk @ 3:15pm)
Room | 255E
May 4, 2025 at 12:02 PM
Today @ #ARVO2025: Brigitte Arduini will present "Preclinical safety and efficacy of an adult progenitor cell product, RPESC-RPE-4W, as therapy for dry Age-Related #MacularDegeneration"
Session Info
Title | Stem cell and gene therapy
Time | 3:15 - 5pm (talk @ 3:15pm)
Room | 255E
Session Info
Title | Stem cell and gene therapy
Time | 3:15 - 5pm (talk @ 3:15pm)
Room | 255E
In 1 week, our own Dylan Murphy will be a guest presenter for the Opalka Gallery PechaKucha night! PechaKucha is a style of presenting in which each person has 20 slides, with 20 seconds to go over each slide, typically using only images. Dylan will present on Charles Darwin's Voyage on the Beagle!
May 2, 2025 at 12:04 PM
In 1 week, our own Dylan Murphy will be a guest presenter for the Opalka Gallery PechaKucha night! PechaKucha is a style of presenting in which each person has 20 slides, with 20 seconds to go over each slide, typically using only images. Dylan will present on Charles Darwin's Voyage on the Beagle!